Search

Recce

Suite 10, 3 Brodie Hall Drive, Technology Park, BENTLEY, 6102
08 9253 9800
Recce is a biotech firm, founded by Chemeq founder Graham Melrose, which developed RECCE (brand) antibiotics. RECCE antibiotics kill both susceptible bacteria and drug resistant “super bugs” – a worldwide health danger arising from resistance to conventional, present-day antibiotics. The company listed on the ASX in 2016 following a successful IPO in late 2015.
Bio last updated 04 Apr 2017

Article Timeline

Access to our data for Recce is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Recce is included in 1 list - Public Companies - Industrial.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

To access ,

Recce (RCE)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
144thUltima United90%5%
516thRecce-7%0%
597thUltracharge-18%2%
798thPLC Financial Solutions-68%10%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/03/17
$20k Sold
16/01/17
$0 Bought
16/01/17
$0 Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

180th↓Recce$139k
202nd-Kabuni$10k
204th-PLC Financial Solutions$6k
206th↓Ultracharge$3k
207th↓Ultima United$2k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer